Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-28 @ 1:39 PM
Study NCT ID:
NCT05867550
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2023-04-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Sponsor:
Bahria University
Organization:
Study Overview
Official Title:
To Compare the Efficacy of (Rifaximin + Mebeverine), (Rifaximin + Amitriptyline), and (Rifaximin + Psyllium Husk) in Irritable Bowel Syndrome Associated With Diarrhea
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the efficacy of four different drugs in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is:
* Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea?
Participants will be divided into 3 treatment groups.
* Each group will be given a combination of drugs for 2 weeks
* At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups
* Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea?
Participants will be divided into 3 treatment groups.
* Each group will be given a combination of drugs for 2 weeks
* At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups
Detailed Description:
The goal of this clinical trial is to compare the efficacy of four different drugs (Rifaximin , Mebeverine, Amitriptyline and Psyllium Husk) in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is:
• Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea?
Total of 162 Participants will be enrolled in study.
* Participants will be divided into 3 treatment groups i.e. Group A, Group B and Group C.
* Participants of Group A will receive drug combination of Rifaximin and Mebeverine
* Participants of Group B will receive drug combination of Rifaximin and Amitriptyline
* Participants of Group C will receive drug combination of Rifaximin and Psyllium Husk
* Each group will be given a combination of drugs for 2 weeks
Stool Frequency, Characteristic of Stool and Abdominal Pain will be assessed at day 0 and day 14 of intervention
Data will be collected using Questionnaire. Questionnaire will be filled by the researcher
SPSS will be used for analysis of data and appropriate test like Chi square Test, Student T test and One way ANOVA will be used to draw conclusions about the efficacy of different drug combinations and their potential side effects between the treatment groups
• Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea?
Total of 162 Participants will be enrolled in study.
* Participants will be divided into 3 treatment groups i.e. Group A, Group B and Group C.
* Participants of Group A will receive drug combination of Rifaximin and Mebeverine
* Participants of Group B will receive drug combination of Rifaximin and Amitriptyline
* Participants of Group C will receive drug combination of Rifaximin and Psyllium Husk
* Each group will be given a combination of drugs for 2 weeks
Stool Frequency, Characteristic of Stool and Abdominal Pain will be assessed at day 0 and day 14 of intervention
Data will be collected using Questionnaire. Questionnaire will be filled by the researcher
SPSS will be used for analysis of data and appropriate test like Chi square Test, Student T test and One way ANOVA will be used to draw conclusions about the efficacy of different drug combinations and their potential side effects between the treatment groups
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: